FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

425753008: Conventional release cutaneous ointment (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2675420017 Cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module
3541117017 Conventional release cutaneous ointment (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3541118010 Conventional release cutaneous ointment en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release cutaneous ointment Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Is a Ointment false Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Is a Cutaneous dose form true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form intended site Cutaneous true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form release characteristic Conventional release true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has basic dose form Ointment true Inferred relationship Existential restriction modifier
Conventional release cutaneous ointment Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely povidone iodine 100 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely nystatin 100000 unit/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Chamomile extracts 10.5% ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mineral oil 500 milligram/1 gram and white petrolatum 500 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mineral oil 50 milligram/1 gram and white petrolatum 950 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and oxytetracycline (as oxytetracycline hydrochloride) 30 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely benzalkonium chloride 1 milligram/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinolone acetonide 250 microgram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely povidone iodine 100 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely tacrolimus (as tacrolimus monohydrate) 300 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely retapamulin 10 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely fluticasone propionate 50 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely cod liver oil 114 milligram/1 gram and zinc oxide 380 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely heparinoid 8 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely diflucortolone valerate 3 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely clobetasone butyrate 500 microgram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely cinchocaine hydrochloride 11 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous ointment Has manufactured dose form False Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Curatoderm 4micrograms/g ointment (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Salicylic acid 60% in White soft paraffin (Special Order) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (Teva UK Ltd) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (Accord Healthcare Ltd) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (A A H Pharmaceuticals Ltd) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier
Tacrolimus 0.1% ointment (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form True Conventional release cutaneous ointment Inferred relationship Existential restriction modifier

Start Previous Page 3 of 3

This concept is not in any reference sets

Back to Start